Stock Movers Closing Bell: GoodRx Surges, Opendoor Rallies, Intel Slips
6 snips
Aug 18, 2025 Shares of GoodRx soared by 37% after a cost-cutting partnership with Novo Nordisk, marking a huge trading day. Meanwhile, Opendoor enjoyed a remarkable rally, bolstered by retail trader enthusiasm following a bullish analysis from a hedge fund manager. Contrarily, Intel's stock slid 3% amid speculation about a potential government stake, raising concerns for the beleaguered chipmaker. The podcast also touches on current Treasury market stability and broader business growth opportunities amid fluctuating yields.
AI Snips
Chapters
Transcript
Episode notes
GoodRx Soars On Ozempic Partnership
- GoodRx jumped over 37% after Novo Nordisk cut Ozempic prices and partnered to distribute at U.S. pharmacies.
- The move created the day's biggest intraday surge and made GoodRx the most actively traded U.S. stock.
Opendoor Rally Fueled By Retail Momentum
- Opendoor extended a three-day rally of roughly 60% as retail traders kept buying and volume exploded.
- Social-media-driven momentum followed a plunge that once put the company at risk of delisting.
Eric Jackson's Online Bull Case Sparked Buying
- Retail traders on social media continued to encourage buying, fueling Opendoor's move higher.
- Eric Jackson posted a bull case online that helped trigger renewed investor interest.